Company: Amgen Inc.
Job title: Scientist, Oncology
GEMM-Derived Allograft Models of Pancreatic Cancer: Valuable Tool for Preclinical Evaluation of Combinatorial Immunotherapies 2:30 pm
• Development and characterization of gemm-derived allograft models – advantages over classical syngeneics, and recapitulation of immune and stromal contexture of human PDAC • Utility to evaluation immunotherapy combinations to inflame immunologically cold checkpoint refractory tumorsRead more
day: Day One